Skip to search formSkip to main contentSkip to account menu

Anaplastic Oligoastrocytoma

Known as: Anaplastic Oligoastrocytoma, NOS, Anaplastic Oligoastrocytoma, Not Otherwise Specified, WHO Grade III Mixed Glioma 
A diffuse anaplastic glioma characterized by the presence of both an astrocytic and an oligodendroglial component and the absence of information on… 
National Institutes of Health

Related topics

Related topics

15 relations
AnaplasiaBody tissueCalcinosisCentral Nervous System

Broader (1)

mixed gliomas

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
Abstract The outcome of patients with anaplastic gliomas varies considerably. Whether a molecular classification of anaplastic… 
Highly Cited
2013
Highly Cited
2013
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
PURPOSE Anaplastic oligodendrogliomas, pure (AO) and mixed (anaplastic oligoastrocytoma [AOA]), are chemosensitive, especially if… 
Review
2013
Review
2013
Glioblastoma and other malignant gliomas: a clinical review.
IMPORTANCE Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5… 
Highly Cited
2011
Highly Cited
2011
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic…
PURPOSE A phase I/II trial was performed to evaluate the safety and immunogenicity of a novel vaccination with α-type 1 polarized… 
Highly Cited
2006
Highly Cited
2006
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
PURPOSE Anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA) are treated with surgery and radiotherapy (RT) at… 
Highly Cited
2000
Highly Cited
2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
PURPOSE Little progress has been made in the treatment of adult high-grade gliomas over the last two decades, thus necessitating… 
Review
1999
Review
1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
PURPOSE To determine the antitumor efficacy and safety profile of temozolomide in patients with malignant astrocytoma at first… 
Highly Cited
1996
Highly Cited
1996
Preserved function in brain invaded by tumor.
OBJECTIVE Intrinsic brain tumors can arise within regions of the cortex that are essential to language, motor, and somatosensory… 
Highly Cited
1989
Highly Cited
1989
Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.
A retrospective analysis is presented of factors affecting the length of survival of 285 consecutive adults with newly diagnosed… 
Highly Cited
1988
Highly Cited
1988
Specific chromosomal abnormalities in malignant human gliomas.
Karyotypic analysis of 54 malignant human gliomas (5 anaplastic astrocytomas, 43 glioblastoma multiformes, 3 gliosarcomas, 2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)